RUS  ENG
Full version
JOURNALS // Mendeleev Communications // Archive

Mendeleev Commun., Forthcoming paper (Mi mendc7565)

In press

Encapsulation of paclitaxel in sodium caseinate nanomicelles

S. A. Boikoa, T. S. Kovshovaa, E. N. Krasnoselskayaa, A. A. Nikitinb, D. I. Salnikovacd, Yu. V. Ermolenkoa, A. M. Scherbakovcd, S. E. Gelperinaa

a D. I. Mendeleev University of Chemical Technology of Russia, 125047 Moscow, Russian Federation
b National University of Science and Technology ‘MISIS’, 119049 Moscow, Russian Federation
c Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russian Federation
d Gause Institute of New Antibiotics, 119021 Moscow, Russian Federation

Abstract: A sodium caseinate-based nanoformulation of paclitaxel was developed using a scalable manufacturing process involving high-pressure homogenization and solvent removal. The resulting nanomicelles (~190 nm) demonstrated high colloidal stability, low hemolytic activity and cytotoxicity comparable to that of free paclitaxel and Abraxane®. The development of a simple and scalable sodium caseinate-based paclitaxel nanoformulation without compromising biological activity was deemed feasible.

Keywords: paclitaxel, sodium caseinate, nanomicelles, drug encapsulation, formulation development.

Received: 03.04.2026
Accepted: 10.07.2026
Published online: 29.09.2026

Language: English

DOI: 10.71267/mencom.8058



© Steklov Math. Inst. of RAS, 2026